HK5190A - Iron complexes of 3-hydroxypyrid-2-and-4-ones - Google Patents

Iron complexes of 3-hydroxypyrid-2-and-4-ones

Info

Publication number
HK5190A
HK5190A HK51/90A HK5190A HK5190A HK 5190 A HK5190 A HK 5190A HK 51/90 A HK51/90 A HK 51/90A HK 5190 A HK5190 A HK 5190A HK 5190 A HK5190 A HK 5190A
Authority
HK
Hong Kong
Prior art keywords
aliphatic
aliphatic hydrocarbon
hydrocarbon group
hydroxypyrid
groups
Prior art date
Application number
HK51/90A
Other languages
English (en)
Inventor
Charles Hider Robert
Kontoghiorghes George
Silver Jack
Arthur Stockham Michael
Original Assignee
National Research Development Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corporation filed Critical National Research Development Corporation
Publication of HK5190A publication Critical patent/HK5190A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK51/90A 1983-03-24 1990-01-25 Iron complexes of 3-hydroxypyrid-2-and-4-ones HK5190A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838308055A GB8308055D0 (en) 1983-03-24 1983-03-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK5190A true HK5190A (en) 1990-02-02

Family

ID=10540099

Family Applications (1)

Application Number Title Priority Date Filing Date
HK51/90A HK5190A (en) 1983-03-24 1990-01-25 Iron complexes of 3-hydroxypyrid-2-and-4-ones

Country Status (9)

Country Link
US (2) US4650793A (da)
EP (1) EP0120670B1 (da)
JP (1) JPH0625120B2 (da)
CY (1) CY1504A (da)
DE (1) DE3475706D1 (da)
DK (1) DK159305C (da)
GB (2) GB8308055D0 (da)
HK (1) HK5190A (da)
SG (1) SG54389G (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
GB9209078D0 (en) * 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
EP0767145B1 (en) 1995-10-06 2000-03-15 Calgon Corporation Use of a synergistic composition for scale control
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
GB9723078D0 (en) * 1997-10-31 1998-01-07 Cerebrus Ltd Chemical compounds
US6294152B1 (en) * 1999-01-11 2001-09-25 The University Of Toledo Iron(III) complexes as contrast agents for image enhancement in magnetic resonance imaging
US6767741B1 (en) * 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
AU2001287850A1 (en) * 2000-09-19 2002-04-02 Vitra Pharmaceuticals Limited Iron compositions
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
CN101679263B (zh) 2007-03-28 2014-01-15 阿普泰克斯科技公司 去铁酮的氟化衍生物
EP2268282B1 (en) 2008-04-25 2014-10-29 Apotex Technologies Inc. Liquid formulation for deferiprone with palatable taste
GEP20146008B (en) 2009-07-03 2014-01-10 Apotex Tech Inc Fluorinated derivatives of 3-hydroxypyridin-4-ones
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
ES2623300T3 (es) 2012-04-05 2017-07-10 Vifor (International) Ag Compuestos de complejo de Fe(III)-pirazina para el tratamiento y la profilaxis de estados de deficiencia de hierro y anemias por deficiencia de hierro

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34313A (en) * 1862-02-04 Improvement in ladders and staging for artisans
US3016372A (en) * 1956-12-13 1962-01-09 Searle & Co Glycosides of the pyridone series
AR207322A1 (es) * 1972-12-18 1976-09-30 Merck & Co Inc Procedimiento para preparar complejos de 4,4'-dinitrocarbanilidas con derivados de piridonas 2-y 4-substituidas pirimidin-2-y-6-/nas y tetrahidroquinolonas utiles para la prevencion y tratamiento da la coccidiosis
JPS5953261B2 (ja) * 1973-08-03 1984-12-24 明治製菓株式会社 ２（１ｈ）−ピリドン誘導体の製造法
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
GR78491B (da) * 1982-03-24 1984-09-27 Nat Res Dev
EP0094149B1 (en) * 1982-03-24 1986-09-10 National Research Development Corporation Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
JPS59118792A (ja) * 1982-12-24 1984-07-09 Kyowa Hakko Kogyo Co Ltd セフエム化合物
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325494D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions

Also Published As

Publication number Publication date
GB2136806A (en) 1984-09-26
JPH0625120B2 (ja) 1994-04-06
GB8407180D0 (en) 1984-04-26
US4650793A (en) 1987-03-17
DK159305B (da) 1990-10-01
DK159305C (da) 1991-03-04
EP0120670A1 (en) 1984-10-03
DK165984D0 (da) 1984-03-23
SG54389G (en) 1989-12-08
GB8308055D0 (en) 1983-05-05
USRE36831E (en) 2000-08-22
DE3475706D1 (en) 1989-01-26
GB2136806B (en) 1987-04-15
CY1504A (en) 1990-08-03
DK165984A (da) 1984-09-25
EP0120670B1 (en) 1988-12-21
JPS59181258A (ja) 1984-10-15

Similar Documents

Publication Publication Date Title
HK5190A (en) Iron complexes of 3-hydroxypyrid-2-and-4-ones
HK37590A (en) 3-hydroxypyrid-2-and-4-ones
IE842799L (en) Zinc containing composition
ES445250A1 (es) Un procedimiento para halogenar productos intermedios para la obtencion de anillos de cefem.
IL84537A0 (en) 1h-imidazo(4,5-c)quinolines and pharmaceutical compositions containing certain such compounds
AU583439B2 (en) Prodrugs of rapamycin
ES8405274A1 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
IL70905A0 (en) Carbacycline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES394369A1 (es) Procedimiento para la preparacion de derivados de la isoin-dolina.
ES2000481A6 (es) Procecimiento de preparacion de nuevos derivados del dihidro-2,3 benzofurano
PL329941A1 (en) Novel analoques of vitamin d
DE3372095D1 (en) Novel phenylpiperazine derivatives and process for producing the same
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
HUP9601331A2 (hu) Piperazin- illetve homopiperazinszármazékok, eljárás előállításukra, és ilyen hatóanyagot tartalmazó gyógyászati készítmények
EP0305646A3 (en) 3-Hydroxypyrid-4-ones and pharmaceutical compositions
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
ES395766A1 (es) Procedimiento para la obtencion de derivados de la hidan- toina.
ES454283A1 (es) Procedimiento para la produccion de un peptido.
EP0604667A4 (en) TRANEXAMIC ACID DERIVATIVE AND DERMATOLOGICAL PREPARATION CONTAINING THE SAME.
ES475596A1 (es) Procedimiento para la preparacion de derivados de fenoxial- canolaminas
ES8602676A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
AU543835B2 (en) N-phthalidyl-5-fluorouracil derivatives
IE43602L (en) Benzocycloheptathiophenes
AU1234588A (en) New acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone, processes for preparing them and the pharmaceutical compositions which contain them
PH12683A (en) 3-amino-1-phenyl-1h,5h-benzo-2,4-thiazepines and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)